Clinical Trial

Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy

Study acronym: NR-RALP
Recruiting
View on ClinicalTrials.gov →
Summary
The investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity of the procedure
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-25.
Status change: Not Yet Recruiting → Recruiting 2024-09-14
Trial Details
NCT Number NCT06521710
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Conditions Prostate Cancer, Erectile Dysfunction
Enrollment 10 participants
Start Date 2024-09
Primary Completion 2027-09 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-19